FDA Inspection 886646 — Minaris Regenerative Medicine, LLC

Minaris Regenerative Medicine, LLC — FEI 3003407523

The FDA completed an inspection of Minaris Regenerative Medicine, LLC on June 17, 2014 in Allendale, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 17, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Allendale, NJ (United States)